BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21152980)

  • 1. Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review.
    Hellstrom WJ; Paduch D; Donatucci CF
    Int Urol Nephrol; 2012 Feb; 44(1):61-70. PubMed ID: 21152980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
    Maganty A; Osterberg EC; Ramasamy R
    Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone Therapy: What We Have Learned From Trials.
    Corona G; Torres LO; Maggi M
    J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.
    Shigehara K; Konaka H; Kato Y; Iijima M; Nakashima K; Kawaguchi S; Nohara T; Izumi K; Namiki M; Mizokami A
    Int J Impot Res; 2019 Jan; 31(1):25-30. PubMed ID: 30135606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.
    Ko YH; Kim JJ
    Asian J Androl; 2011 Jul; 13(4):563-8. PubMed ID: 21572448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
    Sarosdy MF
    Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the basis of sexual dysfunction during late-onset hypogonadism.
    Tharakan T; Miah S; Jayasena C; Minhas S
    F1000Res; 2019; 8():. PubMed ID: 30984376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
    Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
    J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.
    Lazarou S; Morgentaler A
    Curr Urol Rep; 2005 Nov; 6(6):476-81. PubMed ID: 16238923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
    Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
    J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male.
    Heaton JP
    Can J Urol; 2002 Dec; 9(6):1677-80. PubMed ID: 12517308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
    Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
    J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea.
    Shigehara K; Konaka H; Sugimoto K; Nohara T; Izumi K; Kadono Y; Namiki M; Mizokami A
    Aging Male; 2018 Jun; 21(2):99-105. PubMed ID: 28920756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of physiotherapy in addition to testosterone replacement therapy on the efficiency of the motor system in men with hypogonadism.
    Bacevičienė R; Valonytė L; Ceponis J
    Medicina (Kaunas); 2013; 49(2):71-7. PubMed ID: 23888342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
    Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
    Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Testosterone Replacement Therapy in Hypogonadal Men.
    Leung KM; Alrabeeah K; Carrier S
    Curr Urol Rep; 2015 Aug; 16(8):57. PubMed ID: 26077352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.